Search Results 481-490 of 17172 for Alkaptonuria
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to establish the Recommended Phase 2 Dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), ...
Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...
This rare disease caused by a buildup of the protein amyloid can affect different organs in different people. Find out how early and accurate diagnosis can ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Learn about the symptoms, causes and treatment of this blood vessel disease, also called IgA vasculitis, that causes a purplish rash on the lower legs.
Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.
A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic ...
The purpose of this study is to assess the efficacy of LNP023 (iptacopan) to induce and maintain remission in patients with active granulomatosis with ...
This observational study is a registry designed to assess the utilization and effectiveness of LUPKYNIS in adult patients with lupus nephritis (LN) in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.